Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective

Godman, Brian and Allocati, Eleonora and Moorkens, Evelien (2019) Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective. Generics and Biosimilars Initiative journal, 8 (3). ISSN 2033-6403

Preview

Text (Godman-etal-GBIJ-2019-Ever-evolving-landscape-of-biosimilars-in-Canada) Godman_etal_GBIJ_2019_Ever_evolving_landscape_of_biosimilars_in_Canada.pdf Accepted Author Manuscript Download (398kB)| Preview

Abstract

Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSArchivematicaHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Item metadata

  Item type:	Article
  ID code:	69797
  Dates:	Date Event 25 September 2019 Published 25 September 2019 Published Online 12 September 2019 Accepted
  Keywords:	biosimilars, Canada, reimbursement, health policies, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all)
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	13 Sep 2019 09:23
  Last modified:	14 May 2021 02:51
  Related URLs:	Journal or Publication
  URI:	https://strathprints.strath.ac.uk/id/eprint/69797